Scientists from Yale and other institutions have discovered that tirzepatide, a drug approved to treat type 2 diabetes, may also be highly effective...
Vous n'êtes pas connecté
A new study from the Karolinska Institutet, published in the journal eClinicalMedicine, reveals that GLP-1 agonists, a type of medication used to treat type 2 diabetes, may also reduce the risk of dementia in patients. This finding could have significant implications for the treatment of older individuals with this common form of diabetes. Type 2 […]
Scientists from Yale and other institutions have discovered that tirzepatide, a drug approved to treat type 2 diabetes, may also be highly effective...
A recent study from the European Sudden Cardiac Arrest Network suggests a potential link between a common medication used to treat high blood pressure...
Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive...
A recent study has shown that the weight-loss drug Ozempic, along with other medications in its class, may significantly lower the risk of heart...
GLP-1 receptor agonists, a diabetic medication may help in reducing alcohol consumption and alcohol-related health problems.
GLP-1 receptor agonists, a diabetic medication may help in reducing alcohol consumption and alcohol-related health problems.
A new treatment, which is set to transform the lives of type two diabetes patients, is now on the PBS - halving its price.
MONDAY, Nov. 11, 2024 -- The weight-loss drug Ozempic can help reduce stroke patients’ risk of a heart attack or death, a new study says. GLP-1...
MONDAY, Nov. 11, 2024 -- The weight-loss drug Ozempic can help reduce stroke patients’ risk of a heart attack or death, a new study says. GLP-1...
Empagliflozin, or Empa, is a medication often used to help people with type 2 diabetes manage their blood sugar. Now, researchers think it might have...